Phase II study of sorafenib combined with gemcitabine and 5-fluorouracil in patients with metastatic renal cell carcinoma: Preliminary results

被引：0
|
作者：
Hongyun, L. [1 ]
Zhihong, C. [1 ]
Xiangqing, Y. [1 ]
Lu, S. [1 ]
Chuanliang, C. [1 ]
Xinan, S. [1 ]
Lin, S. [1 ]
Jun, G. [1 ]
机构：
[1] Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Beijing 100871, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16093
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A Phase I Study of Combination Therapy with Sorafenib and 5-Fluorouracil in Patients with Advanced Hepatocellular Carcinoma
    Takuya Sho
    Mitsuru Nakanishi
    Kenichi Morikawa
    Masatsugu Ohara
    Naoki Kawagishi
    Takaaki Izumi
    Machiko Umemura
    Jun Ito
    Masato Nakai
    Goki Suda
    Koji Ogawa
    Makoto Chuma
    Takashi Meguro
    Michio Nakamura
    Atsushi Nagasaka
    Hiromasa Horimoto
    Yoshiya Yamamoto
    Naoya Sakamoto
    Drugs in R&D, 2017, 17 : 381 - 388
  • [22] Gemcitabine combined with 5-fluorouracil for the treatment of advanced carcinoma of the pancreas
    Gennatas, C
    Michalaki, V
    Mouratidou, D
    Tsavaris, N
    Andreadis, C
    Photopoulos, A
    Voros, D
    IN VIVO, 2006, 20 (02): : 301 - 305
  • [23] A Phase I Study of Combination Therapy with Sorafenib and 5-Fluorouracil in Patients with Advanced Hepatocellular Carcinoma
    Sho, Takuya
    Nakanishi, Mitsuru
    Morikawa, Kenichi
    Ohara, Masatsugu
    Kawagishi, Naoki
    Izumi, Takaaki
    Umemura, Machiko
    Ito, Jun
    Nakai, Masato
    Suda, Goki
    Ogawa, Koji
    Chuma, Makoto
    Meguro, Takashi
    Nakamura, Michio
    Nagasaka, Atsushi
    Horimoto, Hiromasa
    Yamamoto, Yoshiya
    Sakamoto, Naoya
    DRUGS IN R&D, 2017, 17 (03) : 381 - 388
  • [24] Oxaliplatin and 5-fluorouracil for heavily pretreated metastatic breast cancer:: a preliminary phase II study
    Thuss-Patience, PC
    von Minckwitz, G
    Kretzschmar, A
    Loibl, S
    Schaller, G
    Dörken, B
    Reichardt, P
    ANTI-CANCER DRUGS, 2003, 14 (07) : 549 - 553
  • [25] Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma
    Petrini, Iacopo
    Lencioni, Monica
    Ricasoli, Miriam
    Iannopollo, Mauro
    Orlandini, Cinzia
    Oliveri, Filippo
    Bartolozzi, Carlo
    Ricci, Sergio
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (03) : 773 - 780
  • [26] Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma
    Iacopo Petrini
    Monica Lencioni
    Miriam Ricasoli
    Mauro Iannopollo
    Cinzia Orlandini
    Filippo Oliveri
    Carlo Bartolozzi
    Sergio Ricci
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 773 - 780
  • [27] Phase II Study of Axitinib in Sorafenib-Refractory Metastatic Renal Cell Carcinoma
    Rini, Brian I.
    Wilding, George
    Hudes, Gary
    Stadler, Walter M.
    Kim, Sinil
    Tarazi, Jamal
    Rosbrook, Brad
    Trask, Peter C.
    Wood, Laura
    Dutcher, Janice P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (27) : 4462 - 4468
  • [28] Phase II study of 5-fluorouracil and paclitaxel in patients with gemcitabine-refractory pancreatic cancer
    Yoon Jae Kim
    Seungmin Bang
    Jeong Youp Park
    Seung Woo Park
    Jae Bock Chung
    Si Young Song
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 529 - 533
  • [29] Phase II study of 5-fluorouracil and paclitaxel in patients with gemcitabine-refractory pancreatic cancer
    Kim, Yoon Jae
    Bang, Seungmin
    Park, Jeong Youp
    Park, Seung Woo
    Chung, Jae Bock
    Song, Si Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (03) : 529 - 533
  • [30] Phase II trial of 5-fluorouracil, interferon-alpha and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma
    Ellerhorst, JA
    Sella, A
    Amato, RJ
    Tu, SM
    Millikan, RE
    Finn, LD
    Banks, M
    Logothetis, CJ
    CANCER, 1997, 80 (11) : 2128 - 2132
12345